Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition

被引：30

作者：

Essink-Bot, M. L. ^{[1
]}

Rijnsburger, A. J. ^{[1
,3
]}

van Dooren, S. ^{[2
]}

de Koning, H. J. ^{[1
]}

Seynaeve, C. ^{[3
]}

机构：

[1] Univ Rotterdam, Med Ctr, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands

[2] Univ Rotterdam, Med Ctr, Erasmus MC, Dept Med Psychol & Psychotherapy, NL-3000 CA Rotterdam, Netherlands

[3] Univ Rotterdam, Med Ctr, Erasmus MC,Family Canc Clin, Dr Daniel Den Hoed Canc Ctr,Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands

来源：

BREAST | 2006年 / 15卷 / 05期

关键词：

breast cancer surveillance; subjective burden; discomfort; high risk; MRI;

D O I：

10.1016/j.breast.2006.02.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Magnetic resonance imaging (MRI) of the breasts is a promising screening modality for early detection in women at increased breast cancer risk. We investigated the subjective experiences with MRI and the preferences for MRI, mammography or clinical breast examination in 178 high-risk women adhering to a breast cancer surveillance programme. MRI was reported to cause limited discomfort. About 44% preferred MRI as a screening test (mammography: 14%). MRI provided the most reassurance of breast cancer being absent in case of a favourable test result. MRI seems to be acceptable as a screening test for women at increased breast cancer risk and is preferred by them over mammography. (C) 2006 Elsevier Ltd. All rights reserved.

引用

页码：673 / 676

页数：4

共 5 条

[1] Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition [J].

Kriege, M ;

Brekelmans, CTM ;

Boetes, C ;

Besnard, PE ;

Zonderland, HM ;

Obdeijn, IM ;

Manoliu, RA ;

Kok, T ;

Peterse, H ;

Tilanus-Linthorst, MMA ;

Muller, SH ;

Meijer, S ;

Oosterwijk, JC ;

Beex, LVAM ;

Tollenaar, RAEM ;

de Koning, HJ ;

Rutgers, EJT ;

Klijn, JGM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :427-437

[2] Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) [J].

Leach, MO ;

Boggis, CRM ;

Dixon, AK ;

Easton, DF ;

Eeles, RA ;

Evans, DGR ;

Gilbert, FF ;

Griebsch, I ;

Hoff, RJC ;

Kessar, P ;

Lakhani, SR ;

Moss, SM ;

Nerurkar, A ;

Padhani, AR ;

Pointon, LJ ;

Thompson, D ;

Warren, RML .

LANCET, 2005, 365 (9473) :1769-1778

[3] Acceptability of diagnostic tests for breast cancer [J].

Liang, WC ;

Lawrence, WF ;

Burnett, CB ;

Hwang, YT ;

Freedman, M ;

Trock, BJ ;

Mandelblatt, JS ;

Lippman, ME .

BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (02) :199-206

[4] Impact of screening for breast cancer in high-risk women on health-related quality of life [J].

Rijnsburger, AJ ;

Essink-Bot, ML ;

van Dooren, S ;

Borsboom, GJJM ;

Seynaeve, C ;

Bartels, CCM ;

Klijn, JGM ;

Tibben, A ;

de Koning, HJ .

BRITISH JOURNAL OF CANCER, 2004, 91 (01) :69-76

[5] Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination [J].

Warner, E ;

Plewes, DB ;

Hill, KA ;

Causer, PA ;

Zubovits, JT ;

Jong, RA ;

Cutrara, MR ;

DeBoer, G ;

Yaffe, MJ ;

Messner, SJ ;

Meschino, WS ;

Piron, CA ;

Narod, SA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1317-1325

← 1 →